Menu

This Flu Season Killed 172 Kids

Vaccination reduced the risk of death by two-thirds for children with no other health problems.  

Jun 11, 2018
Sukanya Charuchandra

ISTOCK, PEOPLEIMAGESThe Centers for Disease Control and Prevention’s US influenza survey published on June 8 reports the death of one more child, bringing the current tally to 172. This is the highest number reported since the CDC began registering pediatric deaths, except for the H1N1 pandemic that killed 358 children in 2009.


According to The Washington Post, Daniel Jernigan, head of the CDC’s influenza division, says this season was “bad across the population.” The CDC’s new classification system for flu seasons categorized the 2017-18 flu as “high severity” across all ages. “It was happening to everyone, and it seemed to be happening everywhere,” Jernigan adds.


The CDC concocts a new vaccine every year based on predictions of seasonal strains. Despite the CDC’s flu vaccine recommendations, only 38.8 percent of children between the ages of 6 months and 17 years received the immunization this season.


The flu vaccine “reduced the risk of death among children by half for any kids who had underlying medical conditions, and by nearly two-thirds for otherwise healthy children,” Alicia Bird, an epidemiologist in the CDC’s influenza division, tells TIME.


Delays in reporting flu-related deaths to the CDC means the actual number may yet be higher, reports Huffington Post.


See “How Bad Will the Flu Season Get? Forecasters Are Competing to Figure it Out

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!